CO4820391A1 - Compuestos hipolipidemicos de benzotiazepina - Google Patents
Compuestos hipolipidemicos de benzotiazepinaInfo
- Publication number
- CO4820391A1 CO4820391A1 CO99001036A CO99001036A CO4820391A1 CO 4820391 A1 CO4820391 A1 CO 4820391A1 CO 99001036 A CO99001036 A CO 99001036A CO 99001036 A CO99001036 A CO 99001036A CO 4820391 A1 CO4820391 A1 CO 4820391A1
- Authority
- CO
- Colombia
- Prior art keywords
- benzotiazepine
- compound
- formula
- hypolipidemic compounds
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Un compuesto de la fórmula (I).en dondeR1 es H ó metilo, o una sal, solvato o derivado fisiológicamente funcional del mismo.1Un proceso para la fabricación de un compuesto de la fórmula (I) o una sal, solvato, o derivado fisiológicamente funcional del mismo, que comprende:(A) en donde R1 es H, la desalquilación de un compuesto de la fórmula (II)en donde R1a es una mitad alquilo; ó(B) en donde R1 es un metilo, oxidando un compuesto de la fórmula (III)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9800428.6A GB9800428D0 (en) | 1998-01-10 | 1998-01-10 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4820391A1 true CO4820391A1 (es) | 1999-07-28 |
Family
ID=10825042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99001036A CO4820391A1 (es) | 1998-01-10 | 1999-01-08 | Compuestos hipolipidemicos de benzotiazepina |
Country Status (27)
Country | Link |
---|---|
US (1) | US6465451B1 (es) |
EP (1) | EP1045840A1 (es) |
JP (1) | JP2002500220A (es) |
KR (1) | KR20010033988A (es) |
CN (1) | CN1292785A (es) |
AP (1) | AP2000001860A0 (es) |
AR (1) | AR014261A1 (es) |
AU (1) | AU2515599A (es) |
BR (1) | BR9906799A (es) |
CA (1) | CA2317651A1 (es) |
CO (1) | CO4820391A1 (es) |
EA (1) | EA200000623A1 (es) |
GB (1) | GB9800428D0 (es) |
HR (1) | HRP20000468A2 (es) |
HU (1) | HUP0201343A3 (es) |
ID (1) | ID25495A (es) |
IL (1) | IL137040A0 (es) |
IS (1) | IS5551A (es) |
MA (1) | MA26595A1 (es) |
NO (1) | NO20003514L (es) |
NZ (1) | NZ505453A (es) |
PE (1) | PE20000179A1 (es) |
PL (1) | PL341672A1 (es) |
SK (1) | SK10242000A3 (es) |
TR (1) | TR200001816T2 (es) |
WO (1) | WO1999035135A1 (es) |
ZA (1) | ZA9981B (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038727A1 (en) * | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
SE0000772D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
WO2001068096A2 (en) * | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
US20020183307A1 (en) * | 2000-07-26 | 2002-12-05 | Tremont Samuel J. | Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake |
SE0003766D0 (sv) * | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
GB0121337D0 (en) * | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) * | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
KR100935623B1 (ko) | 2001-09-08 | 2010-01-07 | 알비레오 에이비 | 고지혈증 치료를 위한 회장 담즙산 운반(ibat) 억제활성을 가진 벤조티아제핀 및 벤조티아디아제핀 유도체 |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
FR2849024B1 (fr) * | 2002-12-20 | 2007-11-02 | Aventis Pharma Sa | Nouveaux composes chiraux derives d'esters de l'acide hexanoique, procede et intermediaires de preparation, utilisation a la synthese de l'acide 2-(bromomethyl)2-ethyl hexanoique chiral |
GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
EP2367554A4 (en) | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | BILIARY ACID RECYCLING INHIBITORS FOR THE TREATMENT OF OBESITY AND DIABETES |
WO2011150286A2 (en) | 2010-05-26 | 2011-12-01 | Satiogen Pharmaceuticals,Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
RU2619215C2 (ru) | 2010-11-08 | 2017-05-12 | Альбирео Аб | Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты |
SI2637668T1 (sl) | 2010-11-08 | 2016-11-30 | Albiero Ab | IBAT inhibitorji za zdravljenje jetrnih bolezni |
DK2771003T3 (en) | 2011-10-28 | 2017-07-17 | Lumena Pharmaceuticals Llc | Bile acid recycling inhibitors for the treatment of pediatric cholestatic liver disease |
KR20190135545A (ko) | 2011-10-28 | 2019-12-06 | 루메나 파마수티컬즈, 인코포레이티드 | 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제 |
MX2015013196A (es) | 2013-03-15 | 2016-04-15 | Lumena Pharmaceuticals Inc | Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett. |
MX2015013193A (es) | 2013-03-15 | 2016-04-15 | Lumena Pharmaceuticals Inc | Inhibidores del reciclaje de acidos biliares para el tratamiento de colangitis esclerosante primaria y enfermedad inflamatoria intestinal. |
JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
US10709755B2 (en) | 2014-06-25 | 2020-07-14 | Elobix Ab | Solid formulation and method for preventing or reducing coloration thereof |
EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
RU2750937C2 (ru) | 2016-02-09 | 2021-07-06 | Альбирео Аб | Пероральный состав холестирамина и его применение |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
EP3413877B1 (en) | 2016-02-09 | 2021-04-07 | Albireo AB | Oral cholestyramine formulation and use thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
CA3071182A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine pellets, oral cholestyramine formulations and use thereof |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
JP7391048B2 (ja) | 2018-06-05 | 2023-12-04 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
CR20210027A (es) | 2018-06-20 | 2021-04-29 | Albireo Ab | Formulación farmacéutica de odevixibat |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
KR20210126053A (ko) | 2019-02-06 | 2021-10-19 | 알비레오 에이비 | 벤조티아디아제핀 화합물 및 담즙산 조절제로서의 그의 용도 |
TWI835997B (zh) | 2019-02-06 | 2024-03-21 | 瑞典商艾爾比瑞歐公司 | 苯并噻氮呯化合物及其用作膽酸調節劑之用途 |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
MX2021009625A (es) | 2019-02-12 | 2021-11-04 | Mirum Pharmaceuticals Inc | Métodos para incrementar el crecimiento en sujetos pediátricos que tienen enfermedad de hígado colestásico. |
AR120674A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzotiazepina y su uso como ácido biliar |
EP4069247A1 (en) | 2019-12-04 | 2022-10-12 | Albireo AB | Benzothiadiazepine compounds and their use as bile acid modulators |
WO2021110886A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
WO2021110884A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
CN114761080B (zh) * | 2019-12-04 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
AR120682A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar |
JP2023504646A (ja) * | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
WO2021110883A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
FI4069360T3 (fi) | 2019-12-04 | 2024-02-20 | Albireo Ab | Bentsotia(di)atsepiinin yhdisteet ja niiden käyttö sappihapon modulaattoreina |
ES2972045T3 (es) | 2019-12-04 | 2024-06-10 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
EP4243831A1 (en) | 2020-11-12 | 2023-09-20 | Albireo AB | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
AU2021390172A1 (en) | 2020-12-04 | 2023-06-22 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US20230398125A1 (en) | 2022-06-09 | 2023-12-14 | Albireo Ab | Treating hepatitis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995004534A1 (en) | 1993-08-06 | 1995-02-16 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
ZA956647B (en) | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
GB9423172D0 (en) | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
-
1998
- 1998-01-10 GB GBGB9800428.6A patent/GB9800428D0/en not_active Ceased
-
1999
- 1999-01-06 PE PE1999000007A patent/PE20000179A1/es not_active Application Discontinuation
- 1999-01-06 ZA ZA9900081A patent/ZA9981B/xx unknown
- 1999-01-06 AR ARP990100035A patent/AR014261A1/es unknown
- 1999-01-07 CA CA002317651A patent/CA2317651A1/en not_active Abandoned
- 1999-01-07 KR KR1020007007581A patent/KR20010033988A/ko not_active Application Discontinuation
- 1999-01-07 HU HU0201343A patent/HUP0201343A3/hu unknown
- 1999-01-07 JP JP2000527536A patent/JP2002500220A/ja active Pending
- 1999-01-07 TR TR2000/01816T patent/TR200001816T2/xx unknown
- 1999-01-07 EA EA200000623A patent/EA200000623A1/ru unknown
- 1999-01-07 WO PCT/EP1999/000021 patent/WO1999035135A1/en not_active Application Discontinuation
- 1999-01-07 EP EP99904742A patent/EP1045840A1/en not_active Withdrawn
- 1999-01-07 IL IL13704099A patent/IL137040A0/xx unknown
- 1999-01-07 AU AU25155/99A patent/AU2515599A/en not_active Abandoned
- 1999-01-07 AP APAP/P/2000/001860A patent/AP2000001860A0/en unknown
- 1999-01-07 CN CN998036447A patent/CN1292785A/zh active Pending
- 1999-01-07 BR BR9906799-4A patent/BR9906799A/pt not_active IP Right Cessation
- 1999-01-07 SK SK1024-2000A patent/SK10242000A3/sk unknown
- 1999-01-07 US US09/582,907 patent/US6465451B1/en not_active Expired - Fee Related
- 1999-01-07 NZ NZ505453A patent/NZ505453A/xx unknown
- 1999-01-07 MA MA25421A patent/MA26595A1/fr unknown
- 1999-01-07 ID IDW20001337A patent/ID25495A/id unknown
- 1999-01-07 PL PL99341672A patent/PL341672A1/xx not_active Application Discontinuation
- 1999-01-08 CO CO99001036A patent/CO4820391A1/es unknown
-
2000
- 2000-06-27 IS IS5551A patent/IS5551A/is unknown
- 2000-07-07 NO NO20003514A patent/NO20003514L/no not_active Application Discontinuation
- 2000-07-10 HR HR20000468A patent/HRP20000468A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR014261A1 (es) | 2001-02-07 |
JP2002500220A (ja) | 2002-01-08 |
CN1292785A (zh) | 2001-04-25 |
NO20003514L (no) | 2000-09-07 |
WO1999035135A1 (en) | 1999-07-15 |
NZ505453A (en) | 2002-11-26 |
MA26595A1 (fr) | 2004-12-20 |
AP2000001860A0 (en) | 2000-09-30 |
BR9906799A (pt) | 2000-10-10 |
HRP20000468A2 (en) | 2000-10-31 |
KR20010033988A (ko) | 2001-04-25 |
PL341672A1 (en) | 2001-04-23 |
IS5551A (is) | 2000-06-27 |
AU2515599A (en) | 1999-07-26 |
SK10242000A3 (sk) | 2001-02-12 |
CA2317651A1 (en) | 1999-07-15 |
US6465451B1 (en) | 2002-10-15 |
TR200001816T2 (tr) | 2000-11-21 |
PE20000179A1 (es) | 2000-03-16 |
ZA9981B (en) | 2000-07-06 |
IL137040A0 (en) | 2001-06-14 |
NO20003514D0 (no) | 2000-07-07 |
EA200000623A1 (ru) | 2001-04-23 |
ID25495A (id) | 2000-10-05 |
HUP0201343A2 (hu) | 2003-06-28 |
EP1045840A1 (en) | 2000-10-25 |
HUP0201343A3 (en) | 2003-08-28 |
GB9800428D0 (en) | 1998-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4820391A1 (es) | Compuestos hipolipidemicos de benzotiazepina | |
BRPI9917739B8 (pt) | composto intermediário na preparação de inibidores de cox-2 | |
ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
CY1107403T1 (el) | Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης | |
ATE236154T1 (de) | Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung | |
EA200000358A1 (ru) | Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2 | |
NO20014925L (no) | Farmasöytiske forbindelser | |
PT902022E (pt) | Novos derivados de benzofuranona e processo para a sua producao | |
ES2151977T3 (es) | Inhibidores de accion doble que contienen 1,2-diazepina. | |
AR006058A1 (es) | Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido | |
ATE195513T1 (de) | 22-thiavitamin-d3-derivate | |
FI955498A (fi) | Nipekotiinihappojohdannaisia hyytymistä estävinä aineina | |
ATE233264T1 (de) | Polynalbuphinderivat | |
UY26388A1 (es) | Procedimiento para la preparacion de compuestos de pirazolo (4,3-d) pirimidin - 7-onas-3- piridilsulfonilo e intermedios de los mismos. | |
PT1105392E (pt) | Processo para a preparacao de intermediarios de imidazodiazepina | |
ES2195500T3 (es) | Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes. | |
PT98268A (pt) | Processo para a preparacao de indano-pirrolidino-carbamatos | |
ATE308499T1 (de) | Verfahren zur herstellung von anthracyclinederivaten | |
BR9907340A (pt) | Ciclo-heptenos substituìdos, e processo para a produção de um composto | |
PT842924E (pt) | Intermediarios de piridina uteis na sintese de agonistas de receptores beta-adrenergicos | |
EA200001212A1 (ru) | Усовершенствованный способ получения производных норбензоморфана с ценными фармацевтическими свойствами | |
ES2194361T3 (es) | Procedimiento y compuestos intermedios para la preparacion de un herbicida de triazol. | |
DE69004320D1 (de) | Hydroxyphenethylamin-Derivat und dessen Salze, Verfahren zur Herstellung, medizinische Verwendung und Verwendung als spezifisches pharmakologisches Werkzeug. | |
BR0117362B1 (pt) | processo para a preparação de um composto derivado de 2-piridilmetilamina de fórmula geral (v) | |
BR8900601A (pt) | Processo para a preparacao de compostos de 1,2-dissulfona |